Hearing News Watch

Featured image for “Tinnitus Stepped-Care: A Standardized Framework for Clinical Practice”
Dec. 12, 2025

Tinnitus Stepped-Care: A Standardized Framework for Clinical Practice

HHTM
Tinnitus clinical services are not consistently standardized, and there is currently no widely adopted system for credentialing clinician competency in tinnitus care. Although multiple research-based methods exist for the clinical management of tinnitus, no single approach has been proven more effective than the others, and differences in methodology can result in different outcomes. Authored by James A. Henry, PhD, Tinnitus
Featured image for “Amplifon Unveils “The Wish,” a Holiday Campaign Centered on the Power of Listening”
Dec. 11, 2025

Amplifon Unveils “The Wish,” a Holiday Campaign Centered on the Power of Listening

HHTM
MILAN, ITALY – Amplifon, the global leader in hearing services and solutions, has launched its new global holiday campaign, The Wish, celebrating the role of listening as one of the most meaningful gifts we can offer our loved ones. The campaign features photographic stories of a grandmother and her grandson, a father and daughter, and a couple sharing a moment
Featured image for “Sensorion’s SENS-501 Gene Therapy Trial Clears Safety Review by Independent Monitoring Committee”
Dec. 08, 2025

Sensorion’s SENS-501 Gene Therapy Trial Clears Safety Review by Independent Monitoring Committee

HHTM
MONTPELLIER, FRANCE — Sensorion announced that the independent Data Monitoring Committee (DMC) has identified no safety concerns and supports continued enrollment in the Audiogene Phase 1/2 clinical trial evaluating SENS-501, the company’s investigational gene therapy designed to treat a rare form of congenital deafness caused by mutations in the OTOF (otoferlin) gene. The committee’s review included favorable procedural tolerance and no
Featured image for “HearUSA and Hearing Aid Project Partner to Expand Access to Free Hearing Care Nationwide”
Dec. 08, 2025

HearUSA and Hearing Aid Project Partner to Expand Access to Free Hearing Care Nationwide

HHTM
TAMPA, FLORIDA — HearUSA announced the launch of its Wonderful Sound for All initiative in partnership with the Hearing Aid Project (HAP), a program of Sertoma International, aimed at expanding access to hearing care for individuals facing financial barriers. Through the initiative, qualified individuals will be able to receive free hearing aids, hearing screenings, and audiology services at HearUSA hearing
Featured image for “PEDMARK® Study in Japan Shows Significant Reduction in Cisplatin-Related Hearing Loss in Pediatric Patients”
Dec. 02, 2025

PEDMARK® Study in Japan Shows Significant Reduction in Cisplatin-Related Hearing Loss in Pediatric Patients

HHTM
RESEARCH TRIANGLE PARK, N.C. — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, today announced positive topline results from the investigator-initiated Phase 2/3 STS-J01 clinical trial evaluating PEDMARK® (sodium thiosulfate injection) for reducing cisplatin-induced ototoxicity in pediatric and adolescent and young adult (AYA) patients with non-metastatic solid tumors in Japan. PEDMARK® is the first and only U.S. Food
Featured image for “Sound Pharmaceuticals Receives FDA Breakthrough Therapy Designation for SPI-1005 in Meniere’s Disease”
Dec. 01, 2025

Sound Pharmaceuticals Receives FDA Breakthrough Therapy Designation for SPI-1005 in Meniere’s Disease

HHTM
SEATTLE, WASHINGTON — Sound Pharmaceuticals (SPI) announced that the U.S. Food and Drug Administration (FDA) has granted its investigational drug, SPI-1005, Breakthrough Therapy Designation (BTD) for the treatment of hearing loss associated with Meniere’s disease (MD). MD is a complex inner ear disorder involving low-to-mid frequency hearing loss, tinnitus, vertigo, and dizziness. This marks the first BTD granted for a
Featured image for “Cilcare Wins First Prize at the 2025 Enterprise Europe Network Awards”
Dec. 01, 2025

Cilcare Wins First Prize at the 2025 Enterprise Europe Network Awards

HHTM
AALBORG, DENMARK – Cilcare has been awarded the First Prize at the 2025 Enterprise Europe Network (EEN) Awards, recognizing the company’s successful use of EEN support to advance its work in hearing loss research. CEO and co-founder Celia Belline accepted the award in Aalborg, where three finalists competed for the distinction. Millions of people worldwide live with hearing loss, yet treatment
Featured image for “Expanding the Hearing Health Care Team”
Nov. 30, 2025

Expanding the Hearing Health Care Team

HHTM
by Terry Mactaggart, President and CEO, Summus Hearing If the hearing health problem is to be confronted effectively, we need to weave hearing care into more corners of health and community life. Beyond family physicians (who are typically unengaged and need to be incented), the current array includes the following: Licensed Hearing Care Professionals Approximately 27,000 hearing health providers are
Featured image for “2025 Oticon Focus on People Awards Recognize Individuals Advancing Inclusion in Hearing Loss”
Nov. 24, 2025

2025 Oticon Focus on People Awards Recognize Individuals Advancing Inclusion in Hearing Loss

HHTM
SOMERSET, NEW JERSEY — The 2025 Oticon Focus on People Awards honored three individuals whose contributions are helping expand understanding of hearing loss and promote greater inclusion. Nearly 100 hearing care professionals from across the United States attended the ceremony in Jupiter, Florida, on November 13. Established in 1997 by Oticon, Inc., the national awards program highlights people who challenge outdated
Featured image for “Audiology Groups Join Push for Clearer Federal Definition of Professional Degree Programs”
Nov. 23, 2025

Audiology Groups Join Push for Clearer Federal Definition of Professional Degree Programs

HHTM
In late October, the American Academy of Audiology (AAA) and the American Speech-Language-Hearing Association (ASHA) joined a broad coalition of healthcare organizations in calling for a more inclusive definition of “professional degree program” as the U.S. Department of Education continues its rulemaking process under the One Big Beautiful Bill Act (H.R. 1). The request was formalized in a letter submitted